XML 19 R8.htm IDEA: XBRL DOCUMENT v3.20.4
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
9 Months Ended
Dec. 31, 2020
Dec. 31, 2019
OPERATING ACTIVITIES    
Net income (loss) $ (5,053) $ 42
Adjustments to reconcile to net cash provided by (used in) operating activities:    
Depreciation 237 239
Amortization 429 452
Goodwill and other asset impairment charges 236 113
Equity earnings and charges from investment in Change Healthcare Joint Venture 0 1,478
Deferred taxes (1,520) (387)
Credits associated with last-in, first-out inventory method (115) (114)
Non-cash operating lease expense 264 276
Loss from sales of businesses and investments 50 8
Other non-cash items 67 534
Changes in assets and liabilities, net of acquisitions:    
Receivables 1,500 (1,044)
Inventories (2,046) (689)
Drafts and accounts payable (1,240) (929)
Operating lease liabilities (291) (287)
Taxes 184 11
Litigation liabilities 8,067 0
Other 403 17
Net cash provided by (used in) operating activities 1,172 (280)
INVESTING ACTIVITIES    
Payments for property, plant, and equipment (293) (242)
Capitalized software expenditures (134) (96)
Acquisitions, net of cash, cash equivalents, and restricted cash acquired (33) (97)
Proceeds from sales of businesses and investments, net 325 6
Other (75) 20
Net cash used in investing activities (210) (409)
FINANCING ACTIVITIES    
Proceeds from short-term borrowings 5,455 15,852
Repayments of short-term borrowings (5,303) (13,743)
Proceeds from issuances of long-term debt 500 0
Repayments of long-term debt (1,030) (8)
Common stock transactions:    
Issuances 55 89
Share repurchases, including shares surrendered for tax withholding (526) (1,951)
Dividends paid (209) (222)
Other (118) (271)
Net cash used in financing activities (1,176) (254)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash (77) 27
Net decrease in cash, cash equivalents, and restricted cash (291) (916)
Cash, cash equivalents, and restricted cash at beginning of period 4,023 2,981
Cash, cash equivalents, and restricted cash at end of period 3,732 2,065
Less: Restricted cash at end of period included in Prepaid expenses and other (155) 0
Cash and cash equivalents at end of period $ 3,577 $ 2,065